UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A review of the clinical performance of the Aptima HPV assay

Journal of clinical virology, 2016-03, Vol.76, p.S40-S48

2016

Volltextzugriff (PDF)

Brd4 inhibition suppresses HPV16 E6 expression and enhances chemoresponse: A potential new target in cervical cancer therapy

International journal of cancer, 2019-05, Vol.144 (9), p.2330-2338

2019

Volltextzugriff (PDF)

Head-to-Head Comparison of the RNA-Based Aptima Human Papillomavirus (HPV) Assay and the DNA-Based Hybrid Capture 2 HPV Test in a Routine Screening Population of Women Aged 30 to 60 Years in Germany

Journal of clinical microbiology, 2015-08, Vol.53 (8), p.2509-2516

2015

Volltextzugriff (PDF)

Human papillomaviruses and cancer

Radiotherapy and oncology, 2013-09, Vol.108 (3), p.397-402

2013

Volltextzugriff (PDF)

Methylation of CpG 5962 in L1 of the human papillomavirus 16 genome as a potential predictive marker for viral persistence: A prospective large cohort study using cervical swab samples

Cancer medicine (Malden, MA), 2020-02, Vol.9 (3), p.1058-1068

2020

Volltextzugriff (PDF)

brain-specific factor FEZ1 is a determinant of neuronal susceptibility to HIV-1 infection

Proceedings of the National Academy of Sciences - PNAS, 2009-08, Vol.106 (33), p.14040-14045

2009

Volltextzugriff (PDF)

The Ezrin-Radixin-Moesin Family Member Ezrin Regulates Stable Microtubule Formation and Retroviral Infection

Journal of Virology, 2008-05, Vol.82 (9), p.4665-4670

2008

Volltextzugriff (PDF)

Study-based evaluation of the Abbott RealTime High Risk HPV test in comparison to the HC2 HR HPV test in women aged ≥30 years using residual LBC ThinPrep specimens

BMC infectious diseases, 2016-11, Vol.16 (1), p.672-672, Article 672

2016

Volltextzugriff (PDF)

A population-based observational study comparing Cervista and Hybrid Capture 2 methods: improved relative specificity of the Cervista assay by increasing its cut-off

BMC infectious diseases, 2014-12, Vol.14 (1), p.674-674, Article 674

2014

Volltextzugriff (PDF)

Prevention of Cervical Cancer. Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) – Part 2 on Triage, Treatment and Follow-up

Geburtshilfe und Frauenheilkunde, 2019-02, Vol.79 (2), p.160-176

2019

Volltextzugriff (PDF)

Involvement of Brd4 in different steps of the papillomavirus life cycle

Virus research, 2017-03, Vol.231, p.76-82

2017

Volltextzugriff (PDF)

Prevention of Cervical Cancer. Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) – Part 1 with Introduction, Screening and the Pathology of Cervical Dysplasia

Geburtshilfe und Frauenheilkunde, 2019-02, Vol.79 (2), p.148-159

2019

Volltextzugriff (PDF)

Longitudinal Clinical Performance of the RNA-Based Aptima Human Papillomavirus (AHPV) Assay in Comparison to the DNA-Based Hybrid Capture 2 HPV Test in Two Consecutive Screening Rounds with a 6-Year Interval in Germany

Journal of clinical microbiology, 2019-01, Vol.57 (1)

2019

Volltextzugriff (PDF)

A novel recombinant papillomavirus genome enabling in vivo RNA interference reveals that YB-1, which interacts with the viral regulatory protein E2, is required for CRPV-induced tumor formation in vivo

American journal of cancer research, 2014-01, Vol.4 (3), p.222-233

2014

Volltextzugriff (PDF)

HPV16 viral load and physical state measurement as a potential immediate triage strategy for HR-HPV-infected women: a study in 644 women with single HPV16 infections

American journal of cancer research, 2018-01, Vol.8 (4), p.715-722

2018

Volltextzugriff (PDF)

TMEM45A, SERPINB5 and p16INK4A transcript levels are predictive for development of high-grade cervical lesions

American journal of cancer research, 2016-01, Vol.6 (7), p.1524-1536

2016

Volltextzugriff (PDF)

Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) – Part 2 on Triage, Treatment and Follow-up

Geburtshilfe und Frauenheilkunde, 2019-02, Vol.79 (2), p.160-176

2019

Volltextzugriff (PDF)

Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) – Part 1 with Introduction, Screening and the Pathology of Cervical Dysplasia

Geburtshilfe und Frauenheilkunde, 2019-02, Vol.79 (2), p.148-159

2019

Volltextzugriff (PDF)

Irgendwas mit Medien – In einem Start-up oder in einem etablierten Medienunternehmen? Wie Medienunternehmen im Personalrecruiting konkurrenzfähig werden

Change-Strategien für die Medienbranche, p.299-311

Volltextzugriff (PDF)

1 – 19 von 19

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(18)
Buchkapitel
(1)

Sprache

Englisch
(16)
Deutsch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(16)
Life Sciences & Biomedicine
(15)
Humans
(10)
Female
(7)
Oncology
(6)
Papillomavirus Infections - Diagnosis
(6)
Adult
(5)
Cervical Cancer
(5)
Papillomavirus Infections - Virology
(5)
Sensitivity And Specificity
(5)
Virology
(5)
Cervical Cancer Screening
(4)
Early Detection Of Cancer - Methods
(4)
Human Papillomavirus
(4)
Papillomaviridae - Genetics
(4)
Cancer
(3)
Hpv
(3)
Hpv16
(3)
Microbiology
(3)
Middle Aged
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A review of the clinical performance of the Aptima HPV assay

Brd4 inhibition suppresses HPV16 E6 expression and enhances chemoresponse: A potential new target in cervical cancer therapy

Head-to-Head Comparison of the RNA-Based Aptima Human Papillomavirus (HPV) Assay and the DNA-Based Hybrid Capture 2 HPV Test in a Routine Screening Population of Women Aged 30 to 60 Years in Germany

Human papillomaviruses and cancer

Methylation of CpG 5962 in L1 of the human papillomavirus 16 genome as a potential predictive marker for viral persistence: A prospective large cohort study using cervical swab samples

brain-specific factor FEZ1 is a determinant of neuronal susceptibility to HIV-1 infection

The Ezrin-Radixin-Moesin Family Member Ezrin Regulates Stable Microtubule Formation and Retroviral Infection

Study-based evaluation of the Abbott RealTime High Risk HPV test in comparison to the HC2 HR HPV test in women aged ≥30 years using residual LBC ThinPrep specimens

A population-based observational study comparing Cervista and Hybrid Capture 2 methods: improved relative specificity of the Cervista assay by increasing its cut-off

Prevention of Cervical Cancer. Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) – Part 2 on Triage, Treatment and Follow-up

Involvement of Brd4 in different steps of the papillomavirus life cycle

Prevention of Cervical Cancer. Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) – Part 1 with Introduction, Screening and the Pathology of Cervical Dysplasia

Longitudinal Clinical Performance of the RNA-Based Aptima Human Papillomavirus (AHPV) Assay in Comparison to the DNA-Based Hybrid Capture 2 HPV Test in Two Consecutive Screening Rounds with a 6-Year Interval in Germany

A novel recombinant papillomavirus genome enabling in vivo RNA interference reveals that YB-1, which interacts with the viral regulatory protein E2, is required for CRPV-induced tumor formation in vivo

HPV16 viral load and physical state measurement as a potential immediate triage strategy for HR-HPV-infected women: a study in 644 women with single HPV16 infections

TMEM45A, SERPINB5 and p16INK4A transcript levels are predictive for development of high-grade cervical lesions

Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) – Part 2 on Triage, Treatment and Follow-up

Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) – Part 1 with Introduction, Screening and the Pathology of Cervical Dysplasia

Irgendwas mit Medien – In einem Start-up oder in einem etablierten Medienunternehmen? Wie Medienunternehmen im Personalrecruiting konkurrenzfähig werden

Suchergebnisse filtern